IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET).
Saved in:
| Title: | IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET). |
|---|---|
| Authors: | Nochi Z; Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Pia H; Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Bloms-Funke P; Translational Science & Intelligence, Grünenthal GmbH, Aachen, Germany., Boesl I; Clinical Science Development, Grünenthal GmbH, Aachen, Germany., Caspani O; Department of Neurophysiology, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany., Chapman SC; Eli Lilly and Company, Arlington Square, Bracknell, UK., Fardo F; Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Genser B; Mannheim Institute of Public Health, Social & Preventive Medicine, University of Heidelberg, Heidelberg, Germany., Goetz M; MRC Systems GmbH, Heidelberg, Germany., Kostenko AV; Department of Neurophysiology, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany., Leone C; Department of Human Neuroscience, Sapienza University, Rome, Italy., Li T; Teva Branded Pharmaceutical Products R&D, Inc, West Chester, PA, USA., Mouraux A; Institute of Neuroscience (IoNS), UCLouvain, Brussels, Belgium., Pelz B; MRC Systems GmbH, Heidelberg, Germany., Pogatzki-Zahn E; Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany., Schilder A; Department of Neurophysiology, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany., Schnetter E; University Computing Centre, University of Heidelberg, Heidelberg, Germany., Schubart K; ConsulTech GmbH, Berlin, Germany., Stouffs A; Institute of Neuroscience (IoNS), UCLouvain, Brussels, Belgium., Tracey I; Wellcome Centre for Integrative Neuroimaging, FMRIB Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK., Troconiz IF; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain., Truini A; Department of Human Neuroscience, Sapienza University, Rome, Italy., Van Niel J; Mature Products Development, Grünenthal GmbH, Aachen, Germany., Vela JM; Welab Barcelona, Barcelona, Spain., Vincent K; Nuffield Department of Women's and Reproductive Health (NDWRH), University of Oxford, Oxford, UK., Vollert J; Pain Research, Department of Surgery and Cancer, Imperial College London, London, UK., Wanigasekera V; Wellcome Centre for Integrative Neuroimaging, FMRIB Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK., Wittayer M; Department of Neurophysiology, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany., Tankisi H; Department of Clinical Medicine, Aarhus University and Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark., Finnerup NB; Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. finnerup@clin.au.dk., Phillips KG; Neuroscience Next Generation Therapeutics, Eli Lilly and Company, Lilly Innovation Center, Cambridge, MA, USA., Treede RD; Department of Neurophysiology, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany. |
| Source: | Trials [Trials] 2022 Feb 19; Vol. 23 (1), pp. 163. Date of Electronic Publication: 2022 Feb 19. |
| Publication Type: | Clinical Trial Protocol; Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1745-6215 |
|---|---|
| DOI: | 10.1186/s13063-022-06087-1 |
